Cannabinoid receptor 2 is increased in acutely and chronically inflamed bladder of rats.
Cannabinoid receptors 1 and 2 (CB1 and CB2) are G-protein coupled receptors that are expressed throughout the body. Cannabinoid receptors are expressed in the urinary bladder and may affect bladder function. The purpose of this study was twofold: to confirm the presence of cannabinoid receptors in the bladder, the L6/S1 spinal cord, and dorsal root ganglia (DRG), and to determine the effects of acute and chronic bladder inflammation on expression of cannabinoid receptors. Acute or chronic bladder inflammation was induced in rats by intravesical administration of acrolein. Abundance of CB1 and CB2 protein and their respective mRNA was determined using immunoblotting and quantitative real-time PCR, respectively. We confirmed the presence of CB1 and CB2 receptor protein and mRNA in bladder, L6-S spinal cord, and DRG. Acute bladder inflammation induced increased expression of CB2, but not CB1, protein in the bladder detrusor. Chronic bladder inflammation increased expression of bladder CB2 protein and mRNA but not CB1 protein or mRNA. Expression of CB1 or CB2 in spinal cord or DRG was unaffected by acute or chronic bladder inflammation. CB1 and CB2 receptors are present in the bladder and its associated innervation, and CB2 receptors are up-regulated in bladder after acute or chronic inflammation. CB2 receptors may be a viable target for pharmacological treatment of bladder inflammation and associated pain.
Merriam
Fabiola Voznika
FV
Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USA.
Wang
Zun-yi
ZY
Guerios
Simone Domit
SD
Bjorling
Dale E
DE
D000171:Acrolein; D000818:Animals; D003556:Cystitis / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D004195:Disease Models, Animal; D005260:Female; D005727:Ganglia, Spinal / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D043884:Receptor, Cannabinoid, CB1 / Q000235:genetics / Q000378:metabolism; D043885:Receptor, Cannabinoid, CB2 / Q000235:genetics / Q000378:metabolism*; D013116:Spinal Cord / Q000378:metabolism; D013997:Time Factors; D001743:Urinary Bladder / Q000378:metabolism
D012333:RNA, Messenger; D043884:Receptor, Cannabinoid, CB1; D043885:Receptor, Cannabinoid, CB2; D000171:Acrolein
Neurosci Lett. 1998 Sep 4;253(2):123-6
9774165
Urology. 2008 Nov;72(5):1174-8
18468662
J Neurosci. 2004 Dec 15;24(50):11253-63
15601931
Br J Pharmacol. 1996 Aug;118(8):2053-8
8864542
BJU Int. 2007 Jun;99(6):1523-9
17346276
Nat Rev Neurosci. 2003 Nov;4(11):873-84
14595399
Neuroreport. 1998 May 11;9(7):1455-8
9631447
Gastroenterology. 2007 May;132(5):1968-78
17484889
Brain Res. 2006 Feb 3;1071(1):10-23
16472786
Neuroscience. 2005;135(1):235-45
16084654
J Neurosci. 2002 Aug 15;22(16):7147-53
12177210
Pain. 2003 Sep;105(1-2):275-83
14499445
Anesthesiology. 2001 Mar;94(3):507-13; discussion 6A
11374613
Urology. 2007 Jul;70(1):202-8
17656248
Science. 2005 Oct 14;310(5746):329-32
16224028
Eur J Neurosci. 2003 Jun;17(12):2750-4
12823482
Am J Physiol Regul Integr Comp Physiol. 2008 Jul;295(1):R111-22
18448607
Br J Anaesth. 1999 Sep;83(3):442-8
10655916
Pain. 2006 Dec 15;126(1-3):102-14
16844297
Arthritis Res Ther. 2008;10(2):R43
18416822
Mol Pharmacol. 2008 Jul;74(1):20-33
18388242
Pain. 2005 Jul;116(1-2):129-37
15936883
Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3376-80
7724569
Eur J Biochem. 1993 May 15;214(1):173-80
8508790